India as a Second Manufacturing Base for Medical Device OEMs
A second manufacturing base is not just a backup plan. For medical device OEMs, it can become a strategic platform for cost control, regional growth, supply continuity and market access. India is increasingly relevant in this discussion because it offers engineering capability, healthcare demand, policy support and a growing ecosystem for medical device manufacturing.
Dual sourcing should be engineered, not improvised
A second source must reproduce the product in a controlled way. That means drawings, materials, tooling assumptions, process windows, inspection methods, validation strategy and change control need to be aligned from the beginning. A rushed second source can create more risk than it solves if it is treated only as a cheaper supplier.
India can support both local and export strategies
For some OEMs, India may begin as a regional manufacturing and distribution base. For others, it may become an export-support location for selected product lines. The right path depends on product complexity, regulatory route, demand forecast, component localisation and quality requirements.
What to include in a second-base roadmap
The roadmap should start with low-risk product families or pilot volumes and then scale as evidence grows. It should include technical transfer, pilot validation, supplier qualification, commercial terms and continuity planning.
Product-family selection based on risk and localisation feasibility
Technology transfer and DFM review
Pilot build with documented inspection and feedback
Validation and batch traceability plan
Scale-up plan with CAPEX and OPEX separated
How Medevis Healthtech supports OEMs
Medevis Healthtech can help OEMs evaluate India as a second manufacturing base through phased tooling, injection moulding, cleanroom assembly, pilot production and scale-up planning. The focus is controlled migration, not uncontrolled vendor switching.
Comments